id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1994-N-0182-0048,FDA,FDA-1994-N-0182,Transcript of the Pubic Hearing on Acyclovir - Transcript,Other,TR-Transcript,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:45Z,,0,0,090000648070b75e
FDA-1994-N-0182-0009,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:01Z,,0,0,090000648050714a
FDA-1994-N-0182-0027,FDA,FDA-1994-N-0182,Harvard Medical School - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:21Z,,0,0,0900006480507164
FDA-1994-N-0182-0022,FDA,FDA-1994-N-0182,Association of Reproductive Professional - Supplement,Other,SUP-Supplement,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:15Z,,0,0,090000648050715e
FDA-1994-N-0182-0005,FDA,FDA-1994-N-0182,Distribution of FR Notice for Acyclovir Public Hearing - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:57Z,,0,0,0900006480507146
FDA-1994-N-0182-0040,FDA,FDA-1994-N-0182,American Social Health Association - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-08-11T02:40:17Z,,0,0,0900006480507187
FDA-1994-N-0182-0003,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:54Z,,0,0,0900006480507144
FDA-1994-N-0182-0046,FDA,FDA-1994-N-0182,HFD-9 - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:43Z,,0,0,09000064805071be
FDA-1994-N-0182-0013,FDA,FDA-1994-N-0182,"Denise M. Buntin, M.D. - Appearance Request",Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-08-11T02:40:16Z,,0,0,0900006480507150
FDA-1994-N-0182-0020,FDA,FDA-1994-N-0182,American Academy of Dermatology - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,090000648050715a
FDA-1994-N-0182-0031,FDA,FDA-1994-N-0182,Nonprescription Drug Manufacturers Assn. - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:26Z,,0,0,090000648050716f
FDA-1994-N-0182-0030,FDA,FDA-1994-N-0182,Center for Disease Control and Prevention - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:25Z,,0,0,090000648050716e
FDA-1994-N-0182-0049,FDA,FDA-1994-N-0182,Index - List,Other,LST-List,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:47Z,,0,0,090000648070b89e
FDA-1994-N-0182-0018,FDA,FDA-1994-N-0182,National Women's Health Network - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507156
FDA-1994-N-0182-0026,FDA,FDA-1994-N-0182,Infectious Diseases Society of America - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:20Z,,0,0,0900006480507163
FDA-1994-N-0182-0007,FDA,FDA-1994-N-0182,Distribution of FR Notice for Acyclovir Public Hearing - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:59Z,,0,0,0900006480507148
FDA-1994-N-0182-0006,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:58Z,,0,0,0900006480507147
FDA-1994-N-0182-0044,FDA,FDA-1994-N-0182,Harvard Medical School - Letter,Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:41Z,,0,0,09000064805071aa
FDA-1994-N-0182-0019,FDA,FDA-1994-N-0182,University of Kansas Medical Center - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507157
FDA-1994-N-0182-0015,FDA,FDA-1994-N-0182,The Center for Proper Medication Use - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507152
FDA-1994-N-0182-0042,FDA,FDA-1994-N-0182,HFD-336 - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:39Z,,0,0,0900006480507198
FDA-1994-N-0182-0017,FDA,FDA-1994-N-0182,University of Pittsburgh - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507154
FDA-1994-N-0182-0032,FDA,FDA-1994-N-0182,"Denise M. Buntin, M.D., P.C - Wthdrawal",Other,WDL-Withdrawal,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507171
FDA-1994-N-0182-0021,FDA,FDA-1994-N-0182,Infectious Diseases Society for Ob-Gyn - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,090000648050715b
FDA-1994-N-0182-0033,FDA,FDA-1994-N-0182,HFD-9 - List,Other,LST-List,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:29Z,,0,0,0900006480507173
FDA-1994-N-0182-0045,FDA,FDA-1994-N-0182,HFD-9 - List,Other,LST-List,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:42Z,,0,0,09000064805071ab
FDA-1994-N-0182-0014,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:07Z,,0,0,0900006480507151
FDA-1994-N-0182-0034,FDA,FDA-1994-N-0182,Nonprescription Drug Manufacturers Assn. - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507181
FDA-1994-N-0182-0039,FDA,FDA-1994-N-0182,American Medical Women's Association - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:31Z,,0,0,0900006480507186
FDA-1994-N-0182-0012,FDA,FDA-1994-N-0182,Association of Reproductive Health Professionals - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-28T01:40:44Z,,0,0,090000648050714f
FDA-1994-N-0182-0010,FDA,FDA-1994-N-0182,University of Washington School of Medicine - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:29Z,,0,0,090000648050714b
FDA-1994-N-0182-0001,FDA,FDA-1994-N-0182,Proposed Switch of Acyclovir from Prescription to Over-the-Counter Status; Public Hearing - Notice of Hearing Before the Commissioner,Notice,NHC-Notice of Hearing Before Commissioner,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,1994-06-21T03:59:59Z,2008-12-23T21:00:51Z,,0,0,0900006480507142
FDA-1994-N-0182-0002,FDA,FDA-1994-N-0182,Joint Meeting of the Antiviral Drugs and Nonprescription Drugs Advisory Committees - Notice of Meeting,Notice,NM-Notice of Meeting,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:52Z,,0,0,0900006480507143
FDA-1994-N-0182-0016,FDA,FDA-1994-N-0182,American Society of Hospital Pharmacists - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-28T01:40:44Z,,0,0,0900006480507153
FDA-1994-N-0182-0025,FDA,FDA-1994-N-0182,HFD-9 - List,Other,LST-List,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:19Z,,0,0,0900006480507162
FDA-1994-N-0182-0035,FDA,FDA-1994-N-0182,American Academy of Dermatology - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:31Z,,0,0,0900006480507182
FDA-1994-N-0182-0036,FDA,FDA-1994-N-0182,Assn. of Reproductive Health Professionals - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-28T01:40:45Z,,0,0,0900006480507183
FDA-1994-N-0182-0028,FDA,FDA-1994-N-0182,Center for Proper Medication Use - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:22Z,,0,0,090000648050716b
FDA-1994-N-0182-0008,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:00Z,,0,0,0900006480507149
FDA-1994-N-0182-0023,FDA,FDA-1994-N-0182,NANPRH - Supplement,Other,SUP-Supplement,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:17Z,,0,0,0900006480507160
FDA-1994-N-0182-0024,FDA,FDA-1994-N-0182,American Medical Association - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-08-11T04:13:53Z,,0,0,0900006480507161
FDA-1994-N-0182-0043,FDA,FDA-1994-N-0182,HFD-9 - Letter,Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:40Z,,0,0,09000064805071a6
FDA-1994-N-0182-0029,FDA,FDA-1994-N-0182,HFD-9 - List,Other,LST-List,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:23Z,,0,0,090000648050716c
FDA-1994-N-0182-0037,FDA,FDA-1994-N-0182,Center for Proper Medication Use - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:31Z,,0,0,0900006480507184
FDA-1994-N-0182-0038,FDA,FDA-1994-N-0182,American Society of Hospital Pharmacists - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:31Z,,0,0,0900006480507185
FDA-1994-N-0182-0047,FDA,FDA-1994-N-0182,HFD-9 - Memorandum of Meeting,Other,MM-Memorandum of Meeting,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:44Z,,0,0,09000064805071c1
FDA-1994-N-0182-0041,FDA,FDA-1994-N-0182,Univeristy of Florida - Supplement,Other,SUP-Supplement,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:38Z,,0,0,0900006480507193
FDA-1994-N-0182-0011,FDA,FDA-1994-N-0182,National Association of Nurse Practitioners in Reproductive Health - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:29Z,,0,0,090000648050714e